Product Description
BLI-4900 is being developed by Braintree Laboratories for the colonoscopy bowel preparation in patients. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03328507?term=BLI-4900&draw=2&rank=1)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Nondrug
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Company: Braintree Laboratories
Company Location: Eastern America
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Other
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT03328507 |
BLI4900-201 | P2 |
Completed |
Other |
2019-11-12 |
2023-10-25 |
Patient Enrollment|Primary Endpoints|Treatments |
Recent News Events
Date |
Type |
Title |
|---|